Leslie Orne joined Trinity Life Sciences in 2001 and was recently appointed CEO and president of the fast-growing healthcare consultancy. She previously held the title of chief commercial officer (CCO) and president.
George Freeman MP, minister of state at the new Department for Science, Innovation and Technology, has praised a decade of growth at Discovery Park, the leading science and innovation campus in Sandwich, Kent.
JSR Corporation has acquired Crown Bioscience for more than $405m – the company’s largest investment to date as it turns its attention towards preclinical support for biopharma, says Life Sciences president.
Parexel has partnered with Microsoft to advance patient-centric technologies and help deliver on the promise of personalized medicine following a need for efficiency and innovation in drug development.
GSK has announced a shakeup of its UK network, shelving plans for Ulverston biopharma plant, mooting the sale of its cephalosporin antibiotics business and pledging to invest in HIV and respiratory drug capacity.
As clinical trials “continue to shift to emerging markets,” the translation company Welocalize has acquired Global Language Solutions (GLS) to further support its clients’ linguistic validation processes.
European life sciences received an unexpected boost as the European
Science Foundation launched an initiative to help promote and
coordinate interaction among European life sciences researchers and
Court Square, a provider of IT service offerings for both large and
small biopharma firms, has seized upon what it saw as a gap in the
market to open up a dedicated life sciences division for small and
medium-sized companies (SMEs).
Invitrogen has created three new business divisions in a move to
strengthen its position in the growing biotechnology industry and
drive growth through improving links between its product
development cycle and customer base.
Life sciences investment group Abingworth Management has announced
the initial Abingworth BioEquities Fund (ABE) has raised $53
million (€44 million) to invest across the life sciences field
including human therapeutics.
Emerson Process Management has stepped up its efforts to sell its
engineering, process control and digital automation technologies
into the life sciences sector with the launch of a new programme,
called OpX, at the Interphex exhibition...
France's drug industry has started filling in the detail of its
strategic plan to boost the standing of the biotechnology sector,
first unveiled at the end of last month. At the heart of the plans
is a quadrupling of the production...
Purification and filtration systems manufacturer Pall has reported
flat fiscal fourth-quarter earnings that missed analysts'
expectations, although group sales grew by 7 per cent to $504.5
The enlargement of the European Union to include 10 new countries
has raised fears about the impact this could have on issues such as
parallel imports and intellectual property protection, but it could
reinvigorate the industry in...
In its first progress report since adopting the EU strategy on life
sciences and biotechnology in 2002, the European Commission
yesterday indicated that the risk of diverging policies in Member
States could seriously hamper the effectiveness...